Keywords
Mouth
Diagnosis Oral
Osteonecrosis
Bisphosphonate-Associated Osteonecrosis of the Jaw
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To describe the relationship between bisphosphonates and osteonecrosis in Dentistry. Literature review: Osteonecrosis induced by the continuous use of bisphosphonates is a pathological disease whose main characteristic is the appearance of an area with exposed bone in the oral cavity. American Association of Oral and Maxillofacial Surgeons advises health professionals involved in the treatment of mandibular osteonecrosis in the initial stages (I) that the therapy should consist of the use of antiseptic mouthwashes and antibiotics to control the infection. In advanced stages (II and III) more invasive treatment is recommended. Early-stage diagnosis of mandibular osteonecrosis with an appropriate treatment plan for the case in question may be more beneficial for the patient compared to a diagnosis of the disease in advanced stages. However, each circumstance needs to be treated individually. Final considerations: Early diagnosis of osteonecrosis along with an appropriate treatment plan will be beneficial to the patient, as treatment persists more conservatively.
References
BETH T, et al. Interventions for managing medication-related osteonecrosis of the jaw (Review) SUMMARY OF FINDINGS FOR THE MAIN COMPARISON. Cochrane Library, 2017; CD012432: 10(1–56).
DURÁN JÁC, et al. The role of Leucocyte-rich and platelet-rich fibrin (L-PRF) in the treatment of the medication-related osteonecrosis of the jaws (MRONJ). Journal of Clinical and Experimental Dentistry, 2017; 9(8): e1051–e1059.
CEPONIS P, et al. Hyperbaric oxygen therapy and osteonecrosis. Oral Diseases, 2017; 23(2): 141–151.
DUNPHY L, et al. Medication-related osteonecrosis (MRONJ) of the mandible and maxilla. BMJ Case Reports, 2020; 13: 1.
EGUIA A, et al. Review and update on drugs related to the development of osteonecrosis of the jaw. 2020; 25: 1.
ENDO Y, et al. Underlying mechanisms and therapeutic strategies for bisphosphonate-related osteonecrosis of the jaw (BRONJ). Biological and Pharmaceutical Bulletin, 2017; 40(6): 739–750.
GOODDAY RH. Preventive Strategies for Patients at Risk of Medication-related Osteonecrosis of the Jaw. Oral and Maxillofacial Surgery Clinics of North America, 2015; 27(4): 527–536.
GUPTA A, et al. Rehabilitation of Edentulism and Mortality: A Systematic Review. Journal of Prosthodontics, 2019; 28(5): 526–535.
HADZIC S, et al. Importance of Early Detection of Potentially Malignant Lesions in the Prevention of Oral Cancer. Materia Socio Medica, 2017; 29(2): 129.
HENIEN M, et al. Spontaneous osteonecrosis of the maxilla. Dental Update, 2016; 43(6): 563–566.
KHALFI L, et al. Osteonecrosis Mandibular Extended to Bisphosphonates: A Very Rare Extensive Case. Cureus, 2020; 12(3).
KHAN AA, et al. J BMR Diagnosis and Management of Osteonecrosis of the Jaw : A Systematic Review and International Consensus, 2015; 30(1): 3–23.
KUROSHIMA S, et al. Medication-related osteonecrosis of the jaw: A literature review. Journal of Oral Biosciences, 2019; 61(2): 99–104.
KUŹNIK A, et al. Bisphosphonates—much more than only drugs for bone diseases. European Journal of Pharmacology, 2020; 866.
MENDES V, et al. Impact of bisphosphonate therapy on dental implant outcomes : An overview of systematic review evidence. International Journal of Oral & Maxillofacial Surgery, 2018.
MIGLIORATI CA, et al. Medication-Related Osteonecrosis of the Jaws. Journal of the National Cancer Institute - Monographs, 2019; 53: 107–115.
MÜCKE T, et al. Bisphosphonate and Medication-Related Osteonecrosis of the Jaw: A Review. 2016; 1: 212.
OBINATA K, et al. Image findings of bisphosphonate related Osteonecrosis of the Jaws comparing with osteoradionecrosis. Dentomaxilofac Radiol., 2017; 46(5): 20160281.
OMAMI G, Medication-Related Osteonecrosis of the Mandible. Ear, Nose and Throat Journal, 2020; 2–3.
ROSELLA D, et al. Medication-related osteonecrosis of the jaw: Clinical and practical guidelines. Journal of International Society of Preventive and Community Dentistry, 2016; 6(2): 97–104.
ROSINI S, et al. Understanding bisphosphanates and osteonecrosis of the jaws: uses and riskd. 2015; 3309–3317.
RUGGIERO SL, Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw. Oral and Maxillofacial Surgery Clinics of North America, 2015; 27(4): 479–487.
SALEHI B, et al. Plant-derived bioactives in oral mucosal lesions: A key emphasis to Curcumin, Lycopene, chamomile, aloe Vera, green tea and coffee properties. Biomolecules, 2019; 9(3).
SANTOS M, et al. Extensive osteonecrosis of the maxilla caused by bisphosphonates: Report of a rare case. Journal of Clinical and Experimental Dentistry, 2019; 11(2): e203–e207.
SHIM Y, et al. Analysis of Factors Associated with the Postoperative Healing of Medication-Related Osteonecrosis of the Jaw in Patients with Osteoporosis. 2021.
SILVA LF, et al. Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review. 2015.
SMITH JD, et al. Maxilla Osteonecrosis: A Differential Diagnosis in Patients with Metastatic Cancer on Bisphosphonates. Journal of Case Reports in Medicine, 2016; 5: 1–3.
SPANOU A, et al. Management of bisphosphonate-related osteonecrosis of the jaw: A literature review. Oral Diseases, 2015; 21(8): 927–936.
STEINER C, Schleimhauterkrankungen: Differenzial diagnostischer zugang aus kieferchirurgischer sicht. Hautarzt, 2016; 67(10): 816–821.
VILLA A, et al. Leukoplakia—A Diagnostic and Management Algorithm. Journal of Oral and Maxillofacial Surgery, 2017; 75(4): 723–734.
WALKER AW. Microbiota of the Human Body, 2016; 902: 5–32.
WARNAKULASURIYA S. White, red, and mixed lesions of oral mucosa: A clinicopathologic approach to diagnosis. Periodontology, 2000; 80(1): 89–104.
WASSERZUG O, et al. Involvement of the maxillary sinus in bisphosphonaterelated osteonecrosis of the jaw: Radiologic aspects. American Journal of Rhinology and Allergy, 2017; 31(1): 36–39.
ZHANG L, et al. The Oral Microbiota May Have Influence on Oral Cancer. Frontiers in Cellular and Infection Microbiology, 2020; 9.